ArticleInfectious diseases and therapy2026
Streptococcal Pharyngitis in Paediatric Primary Care: Clinical Characteristics, Recurrences, Complications, and Antibiotic Management.
Article in Infectious diseases and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionGroup A streptococcal (GAS) pharyngitis is the most common bacterial infection in childhood. National and international guidelines consistently recommend narrow-spectrum beta-lactams as first-line therapy; however, variability in outpatient management remains substantial. This study aimed to characterize the clinical features, recurrence patterns, and complications of paediatric group A streptococcal pharyngitis in primary care.
methodsWe performed a prospective, multicenter observational study coordinated by the Italian Society of Primary Care Paediatrics from August 2024 to June 2025. Sixty-six primary care paediatricians across all Italian regions enrolled children aged 1-18 years with microbiologically confirmed GAS pharyngitis with positive rapid antigen detection test. Collected data included demographics, clinical presentation, antibiotic therapy, recurrences, complications, and microbiological findings. Statistical analyses were conducted using chi-square or Fisher's exact tests, with p < 0.05 considered statistically significant.
resultsA total of 1464 episodes of GAS pharyngotonsillitis were documented in 1187 children. Among the 1187 children included in the study, 342 (28.8%) were aged < 5 years and 509 (42.9%) were aged 5-8 years. Most cases (99.5%) were uncomplicated, while 7 (0.5%) developed complications, including sinusitis, peritonsillar abscess, and one case of post-streptococcal glomerulonephritis; three patients required hospitalization. Recurrent infections, whether early (≤ 4 weeks) or late, were not associated with a higher risk of complications. Amoxicillin was prescribed as first-line therapy in 77.5% of uncomplicated episodes, and overall, 51.5% of cases were fully adherent to guideline recommendations. Non-adherence was attributable to inappropriate antibiotic selection in 22.9% of episodes and to an incorrect duration of antibiotic therapy in 25.6% of episodes.
conclusionsPaediatric GAS pharyngitis in this nationwide cohort was predominantly benign, with rare complications. Recurrences was not associated with complication risk. Nonetheless, the discrepancy between Italian guideline recommendations and the real-world use of broad-spectrum antibiotics at first episodes underscores the need to strengthen antimicrobial stewardship in primary care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.